Interview with Tim McCarthy, Chairman of Immupharma – 19 Jan 2018
5th February 2018 - 11:31 amTim McCarthy, Chairman of Immupharma discusses the completion of Lupuzor™ pivotal phase III study and initiation of follow up study.
Tim McCarthy, Chairman of Immupharma discusses the completion of Lupuzor™ pivotal phase III study and initiation of follow up study.